Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Catapres
2. Catapresan
3. Catapressan
4. Chlophazolin
5. Clofelin
6. Clofenil
7. Clonidine
8. Clonidine Dihydrochloride
9. Clonidine Monohydrobromide
10. Clonidine Monohydrochloride
11. Clopheline
12. Dihydrochloride, Clonidine
13. Dixarit
14. Gemiton
15. Hemiton
16. Hydrochloride, Clonidine
17. Isoglaucon
18. Klofelin
19. Klofenil
20. M 5041t
21. M-5041t
22. M5041t
23. Monohydrobromide, Clonidine
24. Monohydrochloride, Clonidine
25. St 155
26. St-155
27. St155
1. 4205-91-8
2. Clonidine Hcl
3. 2-(2,6-dichloroanilino)-2-imidazoline Hydrochloride
4. Kapvay
5. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine Hydrochloride
6. St-155
7. Catapresan
8. Jenloga
9. Clonidine (hydrochloride)
10. Nsc-756699
11. 2-(2,6-dichlorophenylamino)-2-imidazoline Hydrochloride
12. W76i6xxf06
13. Dichloranilino Imidazolin
14. 2-((2,6-dichlorophenyl)imino)imidazolidine Monohydrochloride
15. Benzenamine, 2,6-dichloro-n-2-imidazolidinylidene-, Monohydrochloride
16. Chlophazolin
17. Dispaclonidin
18. Normopresan
19. Atensina
20. Barclyd
21. Capresin
22. Caprysin
23. Catanidin
24. Clofelin
25. Clonilou
26. Clonisin
27. Clonistada
28. Dixarit
29. Edolglau
30. Glausine
31. Haemiton
32. Ipotensium
33. Isoglaucon
34. Katapresan
35. Klophelin
36. Iporel
37. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- [cas]
38. Apo-clonidine
39. Clonidil-riker
40. Novo-clonidine
41. Clonid-ophal
42. Nu-clonidine
43. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine Hcl
44. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Monohydrochloride (9ci)
45. 2-[(2,6-dichlorophenyl)amino-2-imidazoline Hydrochloride
46. Bapresan
47. Clonicel
48. Trialox
49. Clonidine Monohydrochloride
50. Smr000466276
51. 205c918
52. Sr-01000075246
53. Einecs 224-121-5
54. Cas-4205-91-8
55. Mfcd00036705
56. N-(2,6-dichlorophenyl)imidazolidin-2-imine;hydrochloride
57. Unii-w76i6xxf06
58. Clonidine-hcl
59. Sr-01000759380
60. Prestwick_73
61. Catapres (tn)
62. 4,5-dihydro-
63. 2-((2,6-dichlorophenyl)amino)-2-imidazoline Hydrochloride
64. 2-imidazoline, 2-(2,6-dichloroanilino)-, Monohydrochloride
65. 2-(2,6-dichlorophenylamino)-2-imidazolin Hydrochlorid [german]
66. Benzenamine, 2,6-dichloro-n-2-imidazolidinylidene-, Hydrochloride
67. Clonidine Hydrochloride [usan:usp:ban:jan]
68. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Monohydrochloride
69. Clonidinehydrochloride
70. N-(2,6-dichlorophenyl)-
71. Chembl1705
72. Clonidine Hydrochloride,(s)
73. Dsstox_cid_24670
74. Dsstox_rid_80388
75. Dsstox_gsid_44670
76. Schembl40751
77. Mls000758256
78. Mls001424222
79. Clonidine Hydrochloride, Solid
80. 2-(2,6-dichlorophenylamino)-2-imidazolin Hydrochlorid
81. Chebi:3758
82. Dtxsid8044670
83. Hy-b0409a
84. Clonidine Hydrochloride (catapres)
85. Hms1568b18
86. Hms3414h03
87. Hms3678h03
88. Pharmakon1600-01500198
89. Bcp14375
90. Clonidine Hydrochloride [mi]
91. Tox21_301552
92. Tox21_500268
93. Bdbm50020341
94. Ccg-40087
95. Clonidine Hydrochloride (jp17/usp)
96. Clonidine Hydrochloride [jan]
97. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine;hydrochloride
98. Nsc756699
99. S2458
100. Clonidine Hydrochloride [usan]
101. Akos005267207
102. Akos024458609
103. Akos028114993
104. Ccg-101051
105. Ccg-212540
106. Ccg-229466
107. Clonidine Hydrochloride [mart.]
108. Clonidine Hydrochloride [vandf]
109. Ks-1253
110. Lp00268
111. Nc00301
112. Nsc 756699
113. Clonidine Hydrochloride [usp-rs]
114. Clonidine Hydrochloride [who-dd]
115. Ncgc00093726-01
116. Ncgc00093726-02
117. Ncgc00180902-01
118. Ncgc00256172-01
119. Ncgc00260953-01
120. Ac-10306
121. Ac-29742
122. Clonidine Hydrochloride, >=98.0% (tlc)
123. Clonidine Hydrochloride [ep Impurity]
124. Clonidine Hydrochloride [orange Book]
125. D1353
126. Eu-0100268
127. Ft-0601096
128. Ft-0665123
129. Sw197681-3
130. Clonidine Hydrochloride [ep Monograph]
131. C 7897
132. Clonidine Hydrochloride [usp Monograph]
133. D00604
134. D81843
135. Clorpres Component Clonidine Hydrochloride
136. A825736
137. Clonidine Hydrochloride 100 Microg/ml In Methanol
138. Combipres Component Clonidine Hydrochloride
139. Clonidine Hydrochloride Component Of Clorpres
140. Q-200880
141. Sr-01000075246-1
142. Sr-01000075246-3
143. Sr-01000759380-5
144. Clonidine Hydrochloride (catapres) [largely Precursor]
145. Clonidine Hydrochloride Component Of Combipres
146. Q27292429
147. 2-[(2,6-dichlorophenyl)imino]imidazolidine Hydrochloride
148. Clonidine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
149. Clonidine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
150. Clonidine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
151. Clonidine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
152. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Hydrochloride (1:1)
153. N-[2,6-bis(chloranyl)phenyl]-4,5-dihydro-1h-imidazol-2-amine Hydrochloride
Molecular Weight | 266.6 g/mol |
---|---|
Molecular Formula | C9H10Cl3N3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 264.994030 g/mol |
Monoisotopic Mass | 264.994030 g/mol |
Topological Polar Surface Area | 36.4 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 222 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Clonidine hydrochloride |
PubMed Health | Clonidine |
Drug Classes | Analgesic, Anesthetic Adjunct, Antihypertensive, Antimigraine, Cardiovascular Agent, Central Nervous System Agent, Diagnostic Agent, Pheochromocytoma |
Drug Label | Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg, and 0.3 mg. The 0.1 mg tablet is equivalent to 0.087 mg of the free base.The fo... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release; Injectable; Tablet |
Route | Injection; Oral |
Strength | 0.2mg; 1mg/10ml (0.1mg/ml); 0.3mg; 5mg/10ml (0.5mg/ml); 0.1mg |
Market Status | Prescription |
Company | Exela Pharma Scs; Anchen Pharms; Actavis Elizabeth; Fresenius Kabi Usa; Unichem; Mutual Pharm; Vintage; Alembic Pharms; Hikma Farmaceutica; Luitpold; Sun Pharm Inds; Zydus Pharms Usa; Carlsbad; Mylan; Impax Labs; Dava Pharms |
2 of 4 | |
---|---|
Drug Name | Kapvay |
Drug Label | KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic agonist available as 0.1 mg or 0.2 mg extended-release tablets for oral administration. Each 0.1 mg and 0.2 mg tablet is equivalent to 0.087 mg and 0.174 mg, re... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 0.1mg; 0.2mg |
Market Status | Prescription |
Company | Concordia Pharms |
3 of 4 | |
---|---|
Drug Name | Clonidine hydrochloride |
PubMed Health | Clonidine |
Drug Classes | Analgesic, Anesthetic Adjunct, Antihypertensive, Antimigraine, Cardiovascular Agent, Central Nervous System Agent, Diagnostic Agent, Pheochromocytoma |
Drug Label | Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg, and 0.3 mg. The 0.1 mg tablet is equivalent to 0.087 mg of the free base.The fo... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release; Injectable; Tablet |
Route | Injection; Oral |
Strength | 0.2mg; 1mg/10ml (0.1mg/ml); 0.3mg; 5mg/10ml (0.5mg/ml); 0.1mg |
Market Status | Prescription |
Company | Exela Pharma Scs; Anchen Pharms; Actavis Elizabeth; Fresenius Kabi Usa; Unichem; Mutual Pharm; Vintage; Alembic Pharms; Hikma Farmaceutica; Luitpold; Sun Pharm Inds; Zydus Pharms Usa; Carlsbad; Mylan; Impax Labs; Dava Pharms |
4 of 4 | |
---|---|
Drug Name | Kapvay |
Drug Label | KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic agonist available as 0.1 mg or 0.2 mg extended-release tablets for oral administration. Each 0.1 mg and 0.2 mg tablet is equivalent to 0.087 mg and 0.174 mg, re... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 0.1mg; 0.2mg |
Market Status | Prescription |
Company | Concordia Pharms |
Sedation
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-29
Pay. Date : 2015-01-16
DMF Number : 12964
Submission : 1998-04-27
Status : Active
Type : II
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-29
Pay. Date : 2015-01-16
DMF Number : 4778
Submission : 1983-01-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5446
Submission : 1984-06-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6307
Submission : 1986-04-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5998
Submission : 1985-05-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4493
Submission : 1982-04-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6357
Submission : 1986-05-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6128
Submission : 1985-11-20
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6376
Submission : 1986-05-30
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5874
Submission : 1985-05-20
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : CEP 1998-112 - Rev 04
Status : Valid
Issue Date : 2024-02-01
Type : Chemical
Substance Number : 477
Certificate Number : R1-CEP 2014-039 - Rev 01
Status : Valid
Issue Date : 2022-11-29
Type : Chemical
Substance Number : 477
Certificate Number : R1-CEP 2003-038 - Rev 00
Status : Valid
Issue Date : 2009-05-14
Type : Chemical
Substance Number : 477
Certificate Number : CEP 2022-326 - Rev 00
Status : Valid
Issue Date : 2024-07-08
Type : Chemical
Substance Number : 477
Certificate Number : R0-CEP 2022-153 - Rev 00
Status : Valid
Issue Date : 2022-11-21
Type : Chemical
Substance Number : 477
Certificate Number : CEP 2004-072 - Rev 01
Status : Valid
Issue Date : 2024-11-07
Type : Chemical
Substance Number : 477
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2041-07-28
US Patent Number : 11918689
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217645
Patent Use Code : U-3944
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-07-28
Patent Expiration Date : 2029-03-29
US Patent Number : 8062667
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217645
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-29
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?